Sweet Strategies in Prostate Cancer Biomarker Research: Focus on a Prostate Specific Antigen

Sweet Strategies in Prostate Cancer Biomarker Research: Focus on a Prostate Specific Antigen A clarion call for early diagnosis of prostate cancer (PCa) can be addressed using new strategies such as aberrant protein glycosylation. Proteins are naturally affected by numerous post-translational modifications, mainly by glycosylation which is associated with physiological and pathological transformation participating in the development of diseases such as various types of cancer, but also neurodegenerative disorders, endocrine abnormalities, AIDS, etc. Therefore, glycoproteins play crucial role in cancer biomarker research and determination of glycosylation is nowadays one of the key analytical tasks. Predominantly used approach based on affinity assays using lectins as glycorecognition elements has become an essential part in the biomedical research with great prospects in the clinical diagnostics. Owing to their ability to specifically recognize saccharide structures, lectins can be applied for binding to different molecules and substrates such as proteins, lipids, cell walls as well as in biological materials, including stem cells and microorganisms. In order to improve the diagnostic potential of well-known cancer biomarkers, lectin-based biosensors and biochips are already being widely used for the detection of glycoproteins. In this review, we will focus on various bioassay strategies for glycoprofiling of a prostate-specific antigen (PSA) with emphasis to modern and prospective techniques suitable for analysis of PSA glycan motifs as biosensors, biochips and mass spectrometry methods. All mentioned methods are suitable for applications in research, diagnosis and therapy of PCa. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png BioNanoScience Springer Journals

Sweet Strategies in Prostate Cancer Biomarker Research: Focus on a Prostate Specific Antigen

Loading next page...
 
/lp/springer_journal/sweet-strategies-in-prostate-cancer-biomarker-research-focus-on-a-lP6zhibS9b
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media New York
Subject
Engineering; Circuits and Systems; Biological and Medical Physics, Biophysics; Nanotechnology; Biomaterials
ISSN
2191-1630
eISSN
2191-1649
D.O.I.
10.1007/s12668-017-0397-z
Publisher site
See Article on Publisher Site

Abstract

A clarion call for early diagnosis of prostate cancer (PCa) can be addressed using new strategies such as aberrant protein glycosylation. Proteins are naturally affected by numerous post-translational modifications, mainly by glycosylation which is associated with physiological and pathological transformation participating in the development of diseases such as various types of cancer, but also neurodegenerative disorders, endocrine abnormalities, AIDS, etc. Therefore, glycoproteins play crucial role in cancer biomarker research and determination of glycosylation is nowadays one of the key analytical tasks. Predominantly used approach based on affinity assays using lectins as glycorecognition elements has become an essential part in the biomedical research with great prospects in the clinical diagnostics. Owing to their ability to specifically recognize saccharide structures, lectins can be applied for binding to different molecules and substrates such as proteins, lipids, cell walls as well as in biological materials, including stem cells and microorganisms. In order to improve the diagnostic potential of well-known cancer biomarkers, lectin-based biosensors and biochips are already being widely used for the detection of glycoproteins. In this review, we will focus on various bioassay strategies for glycoprofiling of a prostate-specific antigen (PSA) with emphasis to modern and prospective techniques suitable for analysis of PSA glycan motifs as biosensors, biochips and mass spectrometry methods. All mentioned methods are suitable for applications in research, diagnosis and therapy of PCa.

Journal

BioNanoScienceSpringer Journals

Published: Feb 23, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off